NL186633B - Werkwijze voor de bereiding van een geneesmiddel met anti-aritmische werking en werkwijze voor de bereiding van daarin toegepaste benzamidederivaten. - Google Patents
Werkwijze voor de bereiding van een geneesmiddel met anti-aritmische werking en werkwijze voor de bereiding van daarin toegepaste benzamidederivaten.Info
- Publication number
- NL186633B NL186633B NLAANVRAGE7503389,A NL7503389A NL186633B NL 186633 B NL186633 B NL 186633B NL 7503389 A NL7503389 A NL 7503389A NL 186633 B NL186633 B NL 186633B
- Authority
- NL
- Netherlands
- Prior art keywords
- preparation
- arrhythic
- effect
- medicinal product
- derivatives used
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US457099A US3900481A (en) | 1974-04-01 | 1974-04-01 | Derivatives of pyrrolidine and piperidine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NL7503389A NL7503389A (nl) | 1975-10-03 |
| NL186633B true NL186633B (nl) | 1990-08-16 |
| NL186633C NL186633C (nl) | 1991-01-16 |
Family
ID=23815433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NLAANVRAGE7503389,A NL186633C (nl) | 1974-04-01 | 1975-03-21 | Werkwijze voor de bereiding van een geneesmiddel met anti-aritmische werking en werkwijze voor de bereiding van daarin toegepaste benzamidederivaten. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US3900481A (nl) |
| JP (2) | JPS5827268B2 (nl) |
| AR (1) | AR210990A1 (nl) |
| BE (1) | BE827354A (nl) |
| CA (1) | CA1054602A (nl) |
| CH (1) | CH618425A5 (nl) |
| CS (1) | CS209846B2 (nl) |
| DE (1) | DE2513916C2 (nl) |
| DK (1) | DK158980C (nl) |
| ES (1) | ES435870A1 (nl) |
| FR (1) | FR2265366B1 (nl) |
| GB (1) | GB1508015A (nl) |
| HU (1) | HU169762B (nl) |
| IE (1) | IE41224B1 (nl) |
| IL (1) | IL46967A (nl) |
| NL (1) | NL186633C (nl) |
| NO (1) | NO144262C (nl) |
| OA (1) | OA04912A (nl) |
| PL (1) | PL95576B1 (nl) |
| SE (1) | SE391336B (nl) |
| SU (1) | SU668599A3 (nl) |
| ZA (1) | ZA751040B (nl) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4197243A (en) * | 1975-04-02 | 1980-04-08 | Yamanouchi Pharmaceutical Co., Ltd. | N-1-Benzyl-3-pyrrolidinyl-4-dimethylamino benzamide derivatives |
| GB1520584A (en) * | 1975-04-02 | 1978-08-09 | Yamanouchi Pharma Co Ltd | 2 - alkoxy - 5 substituted benzamide derivatives and their use in pharmaceutical compositions |
| FI763021A (nl) * | 1975-11-03 | 1977-05-04 | Thomae Gmbh Dr K | |
| US4097481A (en) * | 1976-11-08 | 1978-06-27 | Riker Laboratories, Inc. | Tertiary amide derivatives of pyrrolidine and piperidine |
| US4071524A (en) * | 1976-11-08 | 1978-01-31 | Riker Laboratories, Inc. | Derivatives of urea |
| US4617396A (en) * | 1979-03-19 | 1986-10-14 | Riker Laboratories, Inc. | Process for the preparation of derivatives of piperidine |
| JPS55143967A (en) * | 1979-03-19 | 1980-11-10 | Riker Laboratories Inc | Manufacture of 2*55bis*2*2*22trifluoroethoxy** nn*22piperidylmethyl*benzamide |
| GB2097000B (en) * | 1979-03-19 | 1983-11-30 | Riker Laboratories Inc | Process for the preparation of 1,4-bis(2,2,2-trifluoroethoxy) benzene |
| US4642384A (en) * | 1979-03-19 | 1987-02-10 | Riker Laboratories, Inc. | Process for the preparation of derivatives of pyrrolidine and piperidine |
| US4684733A (en) * | 1979-03-19 | 1987-08-04 | Riker Laboratories, Inc. | Process for the preparation of intermediates of derivatives of pyrrolidine and piperidine |
| US4452983A (en) * | 1981-06-08 | 1984-06-05 | Riker Laboratories, Inc. | Phenolic derivative |
| US4339587A (en) * | 1981-06-08 | 1982-07-13 | Riker Laboratories, Inc. | 5-Benzyloxy or 5-hydroxy-2-(2,2,2-trifluoroethoxy)-N-(2-pyridylmethyl)benzamide |
| US4390716A (en) * | 1981-06-08 | 1983-06-28 | Riker Laboratories, Inc. | Phenolic derivative |
| JPS5970666A (ja) * | 1982-10-15 | 1984-04-21 | Kyowa Hakko Kogyo Co Ltd | １，４−ジヒドロピリジン誘導体 |
| US4656285A (en) * | 1983-11-15 | 1987-04-07 | Riker Laboratories, Inc. | Compound 2-acetamidomethyl-6-methoxy-pyridine |
| US4496734A (en) * | 1983-11-15 | 1985-01-29 | Riker Laboratories, Inc. | Metabolite |
| US4555573A (en) * | 1983-11-15 | 1985-11-26 | Riker Laboratories, Inc. | Certain 6-benzamidomethyl-2(1H)-pyridone derivatives |
| US4497954A (en) * | 1983-11-15 | 1985-02-05 | Riker Laboratories, Inc. | Cyclopentanone derivatives |
| US4599434A (en) * | 1983-11-15 | 1986-07-08 | Riker Laboratories, Inc. | Cyclopentanone derivatives |
| NZ219913A (en) * | 1986-04-25 | 1990-08-28 | Riker Laboratories Inc | Various flecainide derivatives and antibodies raised thereto |
| US5336622A (en) * | 1986-04-25 | 1994-08-09 | Abbott Laboratories | Tracers for use in flecainide fluorescence polarization immunoassay |
| EP0242847B1 (en) * | 1986-04-25 | 1993-06-02 | Abbott Laboratories | Tracers for use in flecainide fluorescence polarization immunoassay |
| US4952574A (en) * | 1988-09-26 | 1990-08-28 | Riker Laboratories, Inc. | Antiarrhythmic substituted N-(2-piperidylmethyl)benzamides |
| US4938966A (en) * | 1988-11-30 | 1990-07-03 | Riker Laboratories, Inc. | Controlled release flecainide acetate formulation |
| US5254569A (en) * | 1991-01-14 | 1993-10-19 | The Du Pont Merck Pharmaceutical Company | (Amidomethyl)nitrogen heterocyclic analgesics |
| IL121288A (en) * | 1997-07-11 | 2000-10-31 | Finetech Ltd | Process and a novel intermediate for the preparation of flecainide |
| ITMI20011772A1 (it) * | 2001-08-10 | 2003-02-10 | A M S A Anonima Materie Sint E | Processo per la preparazione della 2,5-bis-(2,2,2-trifluoroetossi)-n-(2-piperidilmetil)-benzamide(flecainide) |
| EP1500651A1 (en) * | 2003-07-25 | 2005-01-26 | Bayer CropScience S.A. | N-[2-(2-Pyridinyl)ethyl]benzamide compounds and their use as fungicides |
| US7196197B2 (en) * | 2003-09-17 | 2007-03-27 | Apotex Pharmachem Inc. | Process for the preparation of Flecainide, its pharmaceutically acceptable salts and important intermediates thereof |
| EP1918280A1 (en) * | 2006-11-06 | 2008-05-07 | "Joint Stock Company Grindeks" | Process for the preparation of 2,5-bis-(2,2,2-trifluoroethoxy)-N-(2-piperidylmethyl)-benzamide and salts thereof |
| KR20140097446A (ko) | 2006-11-20 | 2014-08-06 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 통증 및 소양증 치료용 방법, 조성물 및 키트 |
| JP4946482B2 (ja) | 2007-02-08 | 2012-06-06 | 船井電機株式会社 | 緩衝用梱包材及びｔｖ受像機の緩衝用梱包材 |
| EP3485881B1 (en) | 2009-07-10 | 2024-03-13 | President and Fellows of Harvard College | Permanently charged sodium and calcium channel blockers as anti-inflammatory agents |
| JP6833811B2 (ja) | 2015-08-03 | 2021-02-24 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 荷電イオンチャネル遮断薬及び使用方法 |
| WO2020185881A1 (en) | 2019-03-11 | 2020-09-17 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US10780083B1 (en) | 2019-03-11 | 2020-09-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| CA3129089A1 (en) | 2019-03-11 | 2020-09-17 | Bridget Mccarthy Cole | Ester substituted ion channel blockers and methods for use |
| US10828287B2 (en) | 2019-03-11 | 2020-11-10 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US11377422B2 (en) | 2019-03-11 | 2022-07-05 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| JP2023500891A (ja) | 2019-11-06 | 2023-01-11 | ノシオン セラピューティクス，インコーポレイテッド | 荷電したイオンチャンネル遮断薬および使用方法 |
| EP4054586A4 (en) | 2019-11-06 | 2023-11-22 | Nocion Therapeutics, Inc. | CHARGED ION CHANNEL BLOCKERS AND METHODS OF USE |
| WO2021183639A1 (en) | 2020-03-11 | 2021-09-16 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR6209M (nl) * | 1967-04-03 | 1968-07-29 | ||
| US3655728A (en) * | 1970-07-22 | 1972-04-11 | Riker Laboratories Inc | N-(2 - dialkylaminoalkylene)-esters of fluoroalkoxy-substituted aryl carboxylic acid and salts thereof |
| US3719687A (en) * | 1970-07-22 | 1973-03-06 | Riker Laboratories Inc | N-(2-dialkylaminoalkylene)amides of 1,1-dihydroperfluoroalkoxy-substituted aryl acids and salts thereof |
-
1974
- 1974-04-01 US US457099A patent/US3900481A/en not_active Expired - Lifetime
-
1975
- 1975-02-19 ZA ZA00751040A patent/ZA751040B/xx unknown
- 1975-03-21 NO NO750976A patent/NO144262C/no unknown
- 1975-03-21 ES ES435870A patent/ES435870A1/es not_active Expired
- 1975-03-21 DK DK119675A patent/DK158980C/da active
- 1975-03-21 SE SE7503262A patent/SE391336B/xx active Protection Beyond IP Right Term
- 1975-03-21 NL NLAANVRAGE7503389,A patent/NL186633C/nl not_active IP Right Cessation
- 1975-03-27 GB GB13027/75A patent/GB1508015A/en not_active Expired
- 1975-03-27 OA OA55453A patent/OA04912A/xx unknown
- 1975-03-27 CA CA223241A patent/CA1054602A/en not_active Expired
- 1975-03-27 CH CH403075A patent/CH618425A5/de not_active IP Right Cessation
- 1975-03-27 IE IE700/75A patent/IE41224B1/xx unknown
- 1975-03-27 DE DE2513916A patent/DE2513916C2/de not_active Expired
- 1975-03-28 CS CS752168A patent/CS209846B2/cs unknown
- 1975-03-28 FR FR7509953A patent/FR2265366B1/fr not_active Expired
- 1975-03-28 HU HURI561A patent/HU169762B/hu unknown
- 1975-03-28 BE BE154920A patent/BE827354A/xx active Protection Beyond IP Right Term
- 1975-03-31 IL IL46967A patent/IL46967A/xx unknown
- 1975-03-31 SU SU752117802A patent/SU668599A3/ru active
- 1975-03-31 JP JP50039035A patent/JPS5827268B2/ja not_active Expired
- 1975-03-31 AR AR258179A patent/AR210990A1/es active
- 1975-04-01 PL PL1975179258A patent/PL95576B1/pl unknown
-
1982
- 1982-08-27 JP JP57149020A patent/JPS5858347B2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5827268B2 (ja) | 1983-06-08 |
| DK119675A (nl) | 1975-10-02 |
| SE7503262L (nl) | 1975-10-02 |
| NL186633C (nl) | 1991-01-16 |
| IL46967A (en) | 1978-09-29 |
| NO750976L (nl) | 1975-10-02 |
| PL95576B1 (pl) | 1977-10-31 |
| DK158980C (da) | 1991-01-07 |
| ZA751040B (en) | 1976-01-28 |
| IE41224B1 (en) | 1979-11-21 |
| BE827354A (fr) | 1975-09-29 |
| US3900481A (en) | 1975-08-19 |
| ES435870A1 (es) | 1976-12-16 |
| IE41224L (en) | 1975-10-01 |
| CA1054602A (en) | 1979-05-15 |
| FR2265366A1 (nl) | 1975-10-24 |
| IL46967A0 (en) | 1975-05-22 |
| DE2513916C2 (de) | 1982-12-23 |
| NO144262B (no) | 1981-04-21 |
| FR2265366B1 (nl) | 1980-01-11 |
| DE2513916A1 (de) | 1975-10-09 |
| SE391336B (sv) | 1977-02-14 |
| NL7503389A (nl) | 1975-10-03 |
| AU7957875A (en) | 1976-09-30 |
| OA04912A (fr) | 1980-10-31 |
| AR210990A1 (es) | 1977-10-14 |
| NO144262C (no) | 1981-07-29 |
| CS209846B2 (en) | 1981-12-31 |
| DK158980B (da) | 1990-08-13 |
| CH618425A5 (nl) | 1980-07-31 |
| JPS5858347B2 (ja) | 1983-12-24 |
| GB1508015A (en) | 1978-04-19 |
| JPS50137975A (nl) | 1975-11-01 |
| SU668599A3 (ru) | 1979-06-15 |
| JPS5865268A (ja) | 1983-04-18 |
| HU169762B (nl) | 1977-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL186633C (nl) | Werkwijze voor de bereiding van een geneesmiddel met anti-aritmische werking en werkwijze voor de bereiding van daarin toegepaste benzamidederivaten. | |
| NL7503367A (nl) | Werkwijze voor de bereiding van een geneesmiddel met neuro-psychotrope werking. | |
| NL7507798A (nl) | Werkwijze voor de bereiding van een farmaceutisch preparaat. | |
| NL183294B (nl) | Werkwijze voor de bereiding van een 15-deoxy-16-geoxygeneerde prostaanzuurderivaten bevattend geneesmiddel met anti-maagsapafscheidende werking en voor een prostaanzuurderivaat, geschikt voor gebruik bij deze werkwijze. | |
| NL7504234A (nl) | Werkwijze voor de bereiding van carbonamiden met een medicinale werking. | |
| NL7509326A (nl) | Werkwijze voor het bereiden van 18-methyl-19- -nor-20-ketopregnanen, 18-methyl-19-nor-20-keto- -pregnanen, alsmede werkwijze voor de bereiding van een geneesmiddel met centraaldepressieve, anesthetisch-narcotische werking. | |
| NL161462B (nl) | Werkwijze ter bereiding van een farmaceutisch preparaat en werkwijze ter bereiding van daarvoor geschikte verbindingen. | |
| NL183764C (nl) | Werkwijze voor de bereiding van een geneesmiddel met psychotrope of neurotrope werking en werkwijze voor de bereiding van een histidylprolineamide-derivaat. | |
| NL167436C (nl) | Werkwijze voor de bereiding van 7beta-acylamino- -7alfa-alkoxycefalosporinen en 6beta-acylamino- -6alfa- alkoxypenicillinen, alsmede gevormd genees- middel. | |
| NL7512325A (nl) | Werkwijze voor het bereiden van een geneesmiddel. | |
| NL7504216A (nl) | Werkwijze voor de bereiding van een farmaceutisch preparaat. | |
| NL7603619A (nl) | Werkwijze voor de bereiding van sterolglucoside met hemostatische werking, werkwijze voor de bereiding van een geneesmiddel met een derge- lijke werking en geneesmiddel. | |
| NL7513064A (nl) | Werkwijze voor de bereiding van een farmaceutisch preparaat. | |
| NL7412218A (nl) | Werkwijze voor de bereiding van een geneesmid- del met antiflogistische en antipyretische wer- | |
| NL7505521A (nl) | Werkwijze voor de bereiding van anti-arterio- sclerotisch werkzame stoffen, werkwijze voor de bereiding van een geneesmiddel met een dergelij- ke werking en een geneesmiddel. | |
| NL186383C (nl) | Werkwijze voor de bereiding van octahydroindolochinolizinederivaten en werkwijze voor de bereiding van een farmaceutisch preparaat met vaatverwijdende werking, alsmede gevormd farmaceutisch preparaat. | |
| NL7502795A (nl) | Werkwijze voor de bereiding van een geneesmiddel met vaatspan-krachtverhogende, capillair-af- dichtende en/of anti-aritmische werking. | |
| NL7512896A (nl) | Werkwijze voor de bereiding van naftaleen-deriva- ten en werkwijze voor de bereiding van een genees- middel op basis hiervan. | |
| NL7505571A (nl) | Werkwijze voor de bereiding van een geneesmid- del met anti-lipolytische werking. | |
| NL7503110A (nl) | Werkwijze voor de bereiding van een geneesmiddel met ontstekings-remmende werking. | |
| NL7503728A (nl) | Werkwijze voor de bereiding van een geneesmid- del met bronchodilatorische en anti-astmatische werkzaamheid alsmede voor de bereiding van daarvoor geschikte theofyllinederivaten. | |
| NL7506872A (nl) | Werkwijze voor de bereiding van een farmaceutische preparaat. | |
| NL7505520A (nl) | Werkwijze voor de bereiding van een geneesmiddel met anti-bacterie- en anti-protozoenwerking, een geneesmiddel met een dergelijke werking en een werkwijze voor de bereiding van actieve verbin- dingen. | |
| NL7502445A (nl) | Werkwijze voor de bereiding van een geneesmiddel met onder meer androgene werking. | |
| NL7604502A (nl) | Werkwijze voor de bereiding van een geneesmiddel met anti-iflammatore werking, een geneesmiddel met een dergelijke werking en een werkwijze voor de bereiding van de werkzame verbindingen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BA | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| A85 | Still pending on 85-01-01 | ||
| BK | Erratum |
Free format text: CORRECTION TO PAMPHLET |
|
| V4 | Discontinued because of reaching the maximum lifetime of a patent |